Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Progyny Inc.

In a report released today, from Jefferies maintained a Buy rating on Progyny, with a price target of $33.00. In addition to Jefferies, Progyny als...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PGNY	$26.71	+2.69%	1.58M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PGNY	$26.71	+2.7%	1.58M
3
4
5
6

PGNY

PGNY

Latest News for PGNY

Get Progyny Inc. Data in Excel

Get Progyny Inc. Data in Excel